The Efficacy And Safety Profile Of Anlotinib With Etoposide Plus Cisplatin/Carboplatin In Treatment-Naive Extensive-Stage Small Cell Lung Cancer(Sclc) Patients: Results From A Phase Ii Single-Arm Trial.

Pengbo Deng,Huaping Yang,Cen Chen,Chengping Hu,Liming Cao,Qihua Gu,Jian An,Bin Li,Yongjun Tang,Jie Meng,Juntao Feng

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 3|浏览18

暂无评分

摘要

9066Background: Combination of etoposide and cisplatin/carboplatin is the most commonly used initial chemoptherapy regiment in extensive-stage small cell lung cancer. A meta-analysis released that,...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要